| Natera, Inc. Common Stock | $47.2b | $347.97 | -0.7% | 212.3K | |
| Guardant Health, Inc. Common Stock | $21.9b | $176.30 | -0.0% | 311.6K | |
| Caris Life Sciences, Inc. Common Stock | $7.0b | $28.07 | -1.1% | 613.3K | |
| BillionToOne, Inc. Class A Common Stock | $4.5b | $104.31 | -0.4% | 74.6K | |
| Adaptive Biotechnologies Corporation Common Stock | $3.9b | $27.25 | +2.5% | 1.0M | |
| GRAIL, Inc. Common Stock | $3.6b | $75.62 | -0.5% | 393.2K | |
| Veracyte, Inc. | $3.6b | $40.13 | +0.6% | 92.0K | |
| NeoGenomics, Inc. | $2.2b | $19.09 | +0.9% | 234.2K | |
| Personalis, Inc. Common Stock | $1.8b | $16.14 | -0.1% | 276.4K | |
| Castle Biosciences, Inc. Common Stock | $1.0b | $35.74 | +2.0% | 92.5K | |
| AngioDynamics, Inc. | $0.6b | $15.83 | +1.0% | 29.6K | |
| Fulgent Genetics, Inc. Common Stock | $0.6b | $21.43 | 0.0% | 28.8K | |
| The Oncology Institute, Inc. Common Stock | $0.5b | $5.19 | 0.0% | N/A | |
| Myriad Genetics Inc | $308.9m | $3.89 | -0.5% | 223.7K | |
| Biodesix, Inc. Common Stock | $286.6m | $27.56 | -0.4% | 8.3K | |
| Lucid Diagnostics Inc. Common Stock | $189.0m | $0.81 | +1.9% | 161.6K | |
| Quantum Cyber N.V. Ordinary Shares | $127.8m | $1.31 | 0.0% | 107.2K | |
| MDxHealth SA Ordinary Shares | $69.3m | $0.68 | 0.0% | 6.2K | |
| Sensus Healthcare, Inc | $53.7m | $3.19 | 0.0% | 387 | |
| Precipio, Inc. Common Stock | $46.8m | $27.23 | 0.0% | 610 | |
| PAVmed Inc. Common Stock | $40.7m | $4.25 | 0.0% | 75 | |
| Advanced Biomed Inc. Common Stock | $16.1m | $7.97 | 0.0% | 506 | |
| 20/20 Biolabs, Inc. Common Stock | $8.1m | $0.47 | 0.0% | 18.0K | |
| VolitionRx Limited | $6.6m | $0.28 | -1.6% | 309.0K | |
| bioAffinity Technologies, Inc. Common Stock | $5.8m | $6.10 | -4.0% | 56.2K | |
| Zhongchao Inc. Class A Ordinary Shares | $5.4m | $0.75 | 0.0% | 146.1K | |
| Avalon GloboCare Corp. Common Stock | $3.5m | $0.28 | 0.0% | N/A | |
| Onconetix, Inc. Common Stock | $3.2m | $0.67 | 0.0% | 28.6K |